JP2017526651A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2017526651A5 JP2017526651A5 JP2017503611A JP2017503611A JP2017526651A5 JP 2017526651 A5 JP2017526651 A5 JP 2017526651A5 JP 2017503611 A JP2017503611 A JP 2017503611A JP 2017503611 A JP2017503611 A JP 2017503611A JP 2017526651 A5 JP2017526651 A5 JP 2017526651A5
- Authority
- JP
- Japan
- Prior art keywords
- allulose
- less
- tablet
- dry weight
- compressible composition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- LKDRXBCSQODPBY-JDJSBBGDSA-N D-allulose Chemical compound OCC1(O)OC[C@@H](O)[C@@H](O)[C@H]1O LKDRXBCSQODPBY-JDJSBBGDSA-N 0.000 claims 24
- 239000000203 mixture Substances 0.000 claims 11
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims 6
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims 4
- 238000002425 crystallisation Methods 0.000 claims 4
- 230000008025 crystallization Effects 0.000 claims 4
- WQZGKKKJIJFFOK-IVMDWMLBSA-N D-allopyranose Chemical compound OC[C@H]1OC(O)[C@H](O)[C@H](O)[C@@H]1O WQZGKKKJIJFFOK-IVMDWMLBSA-N 0.000 claims 3
- 238000007907 direct compression Methods 0.000 claims 3
- 239000000546 pharmaceutical excipient Substances 0.000 claims 3
- 238000004519 manufacturing process Methods 0.000 claims 2
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims 1
- 239000008280 blood Substances 0.000 claims 1
- 210000004369 blood Anatomy 0.000 claims 1
- 235000009508 confectionery Nutrition 0.000 claims 1
- 235000003599 food sweetener Nutrition 0.000 claims 1
- 239000008103 glucose Substances 0.000 claims 1
- 239000004615 ingredient Substances 0.000 claims 1
- 239000000314 lubricant Substances 0.000 claims 1
- 238000000034 method Methods 0.000 claims 1
- 230000000324 neuroprotective effect Effects 0.000 claims 1
- 230000035790 physiological processes and functions Effects 0.000 claims 1
- 239000003642 reactive oxygen metabolite Substances 0.000 claims 1
- 230000002000 scavenging effect Effects 0.000 claims 1
- 238000007873 sieving Methods 0.000 claims 1
- 230000001629 suppression Effects 0.000 claims 1
- 239000003765 sweetening agent Substances 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP14306180 | 2014-07-21 | ||
| EP14306180.2 | 2014-07-21 | ||
| PCT/IB2015/001303 WO2016012854A1 (en) | 2014-07-21 | 2015-07-16 | Sugar compositions for tableting by direct compression |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2017526651A JP2017526651A (ja) | 2017-09-14 |
| JP2017526651A5 true JP2017526651A5 (https=) | 2018-08-23 |
| JP6803325B2 JP6803325B2 (ja) | 2020-12-23 |
Family
ID=51265636
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2017503611A Active JP6803325B2 (ja) | 2014-07-21 | 2015-07-16 | アルロースの製造方法及び錠剤の製造方法 |
Country Status (12)
| Country | Link |
|---|---|
| US (2) | US10342247B2 (https=) |
| EP (1) | EP3171710B1 (https=) |
| JP (1) | JP6803325B2 (https=) |
| KR (1) | KR102501024B1 (https=) |
| CN (1) | CN106535661B (https=) |
| BR (1) | BR112017001192B1 (https=) |
| CA (1) | CA2955849C (https=) |
| CL (1) | CL2017000136A1 (https=) |
| ES (1) | ES3060158T3 (https=) |
| MX (1) | MX378866B (https=) |
| SG (1) | SG11201700451QA (https=) |
| WO (1) | WO2016012854A1 (https=) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2017158534A (ja) * | 2016-03-07 | 2017-09-14 | 焼津水産化学工業株式会社 | チップ状食品の製造方法及びチップ状食品 |
| US12590116B2 (en) | 2016-10-28 | 2026-03-31 | Tate & Lyle Solutions Usa Llc | Method for producing allulose crystals |
| KR102679582B1 (ko) | 2016-10-28 | 2024-06-27 | 테이트 앤드 라일 솔루션스 유에스에이 엘엘씨 | 알룰로오스 결정의 제조방법 |
| FR3061415B1 (fr) * | 2017-01-05 | 2021-07-16 | Roquette Freres | Sirops non cristallisables de d-allulose |
| FR3061414B1 (fr) * | 2017-01-05 | 2021-07-16 | Roquette Freres | Sirops cristallisables de d-allulose |
| FR3061413B1 (fr) * | 2017-01-05 | 2021-08-27 | Roquette Freres | Procede de fabrication de cristaux de d-allulose |
| CN106955290A (zh) * | 2017-03-24 | 2017-07-18 | 南京顺昌医药科技有限公司 | 一种治疗退化性疾病的组合物及其用途 |
| KR101988442B1 (ko) | 2017-06-30 | 2019-06-12 | 주식회사 삼양사 | 결정형 기능성 감미료 |
| WO2019004555A1 (ko) * | 2017-06-30 | 2019-01-03 | 주식회사 삼양사 | 결정형 기능성 감미료 |
| WO2019004554A1 (ko) * | 2017-06-30 | 2019-01-03 | 주식회사 삼양사 | 결정형 기능성 감미료의 제조방법 |
| MX2020008430A (es) | 2018-02-12 | 2020-12-10 | Samyang Corp | Metodo para producir edulcorante cristalino funcional. |
| EP4029380B1 (en) * | 2019-09-13 | 2026-01-28 | Meiji Co., Ltd | Solid milk |
| EP3864966A1 (de) * | 2020-02-12 | 2021-08-18 | Savanna Ingredients GmbH | Orale zubereitungen mit kristalliner allulose |
| EP4000419A1 (de) | 2020-11-23 | 2022-05-25 | Savanna Ingredients GmbH | Trocknung von allulosekristallen |
Family Cites Families (26)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GR79494B (https=) | 1983-01-07 | 1984-10-30 | Tate & Lyle Ltd | |
| US4692514A (en) | 1985-12-20 | 1987-09-08 | Uop Inc. | Process for separating ketoses from alkaline- or pyridine-catalyzed isomerization products |
| FI104787B (fi) | 1989-06-07 | 2000-04-14 | Xyrofin Oy | Fruktoosipohjainen rakeistettu tuote ja menetelmä sen valmistamiseksi |
| PL329614A1 (en) * | 1996-04-16 | 1999-03-29 | Bayer Ag | D-mannitoll and method of obtaining same |
| FI110095B (fi) * | 1998-05-18 | 2002-11-29 | Xyrofin Oy | Ksylitolin kiteyttäminen, kiteinen ksylitolituote ja sen käyttö |
| JP4473980B2 (ja) | 1999-06-24 | 2010-06-02 | 株式会社林原生物化学研究所 | 糖質複合体結晶とその製造方法 |
| EP3115052B1 (en) | 2002-05-22 | 2019-08-21 | Matsutani Chemical Industry Co., Ltd. | D-psicose for use in the treatment of arteriosclerosis |
| WO2005060937A1 (en) | 2003-12-23 | 2005-07-07 | Chr. Hansen A/S | Compressed tablets comprising viable probiotic microorganisms |
| JP4761424B2 (ja) * | 2004-03-17 | 2011-08-31 | 株式会社希少糖生産技術研究所 | Ｌ−プシコース結晶、その製造方法および、糖試薬キット |
| GT200600008A (es) | 2005-01-18 | 2006-08-09 | Formulacion de compresion directa y proceso | |
| WO2006093292A1 (ja) | 2005-03-04 | 2006-09-08 | National University Corporation Kagawa University | D-プシコースとd-アロースの複合体結晶性糖質およびその製造方法 |
| JP5116071B2 (ja) | 2005-07-20 | 2013-01-09 | 帝國製薬株式会社 | Ｄ−アロースおよびｄ−プシコースの抗神経因性疼痛効果の利用 |
| EP1956088B1 (en) | 2005-11-15 | 2013-10-23 | Hayashibara Co., Ltd. | Ketose 3-epimerase, process for production thereof, and use thereof |
| JP4942001B2 (ja) * | 2006-11-10 | 2012-05-30 | 松谷化学工業株式会社 | Ｄ−プシコース含有甘味料およびそれを使用して得られた飲食品など |
| KR20100018568A (ko) | 2007-05-18 | 2010-02-17 | 마쓰다니가가꾸고오교가부시끼가이샤 | 슈크로오스성 감미질을 가지는 신규 감미료, 그 제조법 및 용도 |
| CN102083410B (zh) | 2007-06-06 | 2013-04-17 | 巴斯夫欧洲公司 | 用于制备迅速崩解的片剂的药物制剂 |
| EP2175740B1 (en) | 2007-07-31 | 2018-06-06 | Cargill, Incorporated | Direct compressible dextrose |
| CN100577793C (zh) * | 2007-12-12 | 2010-01-06 | 江南大学 | 微生物转化d-果糖制备d-阿洛酮糖的菌种和方法 |
| JP5715046B2 (ja) * | 2009-03-30 | 2015-05-07 | 松谷化学工業株式会社 | 目的とするヘキソースを所定量含む原料糖とは異なる糖組成の糖組成物の製造方法および製造された糖組成物の用途 |
| KR101189640B1 (ko) * | 2010-03-26 | 2012-10-12 | 씨제이제일제당 (주) | Ｄ-사이코스 결정을 제조하는 방법 |
| JP2011205913A (ja) * | 2010-03-29 | 2011-10-20 | Kishoto Seisan Gijutsu Kenkyusho:Kk | 機能性異性化糖の複合体結晶糖質およびその製造方法 |
| JP5859191B2 (ja) * | 2010-09-29 | 2016-02-10 | 松谷化学工業株式会社 | 高甘味度甘味料に対する呈味改良組成物およびその応用 |
| JP6099870B2 (ja) | 2012-01-06 | 2017-03-22 | 松谷化学工業株式会社 | スクロースとｄ−プシコースを含む新規甘味料 |
| CN102697744B (zh) | 2012-05-29 | 2013-11-27 | 安吉东来药用辅料有限责任公司 | 阿洛糖片剂赋形剂、药物片剂及药物片剂的制备方法 |
| KR102303570B1 (ko) | 2013-04-26 | 2021-09-16 | 마쓰다니가가꾸고오교가부시끼가이샤 | 에너지 소비의 촉진 및/또는 에너지 소비 기능 저하의 치료 및/또는 예방제, 또는 방법 |
| CN103333935A (zh) | 2013-05-24 | 2013-10-02 | 桐乡晟泰生物科技有限公司 | D-阿洛酮糖的生产工艺 |
-
2015
- 2015-07-16 JP JP2017503611A patent/JP6803325B2/ja active Active
- 2015-07-16 US US15/327,556 patent/US10342247B2/en active Active
- 2015-07-16 SG SG11201700451QA patent/SG11201700451QA/en unknown
- 2015-07-16 BR BR112017001192-1A patent/BR112017001192B1/pt active IP Right Grant
- 2015-07-16 KR KR1020177000681A patent/KR102501024B1/ko active Active
- 2015-07-16 CN CN201580039823.8A patent/CN106535661B/zh active Active
- 2015-07-16 ES ES15778704T patent/ES3060158T3/es active Active
- 2015-07-16 WO PCT/IB2015/001303 patent/WO2016012854A1/en not_active Ceased
- 2015-07-16 MX MX2017000827A patent/MX378866B/es unknown
- 2015-07-16 EP EP15778704.5A patent/EP3171710B1/en active Active
- 2015-07-16 CA CA2955849A patent/CA2955849C/en active Active
-
2017
- 2017-01-18 CL CL2017000136A patent/CL2017000136A1/es unknown
-
2019
- 2019-05-29 US US16/425,014 patent/US20190289888A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2017526651A5 (https=) | ||
| JP2017178948A5 (https=) | ||
| FI3265084T3 (fi) | Brutonin tyrosiinikinaasin estäjän lääkeformulaatioita | |
| JP2012501986A5 (https=) | ||
| JP2016540021A5 (https=) | ||
| JP2021529829A5 (https=) | ||
| JP2010522242A5 (https=) | ||
| PE20061345A1 (es) | Composicion farmaceutica que comprende sorafenib | |
| CL2011000867A1 (es) | Formas cristalinas da, c y ii de (r)-5-[3-cloro-4-(2,3-dihidroxi-propoxi)- benz[z]ilideno]-2- ([z]- propilimino) -3-o- totil-tiazolidin-4-ona; composicion farmaceutica; y uso en el tratamiento o prevencion de rechazo de organos trasplantados, sindrome autoinmunitarios, asma, diabetes, cancer. | |
| JP2014221827A5 (https=) | ||
| JP2016509051A5 (https=) | ||
| WO2013183062A3 (en) | Palatable formulations of ibuprofen | |
| JP2019510079A5 (https=) | ||
| HK1244429A1 (zh) | 特别用於治疗注意力缺陷障碍的方法和组合物 | |
| PH12017502325A1 (en) | Orodispersible dosage unit containing an estetrol component | |
| JP2009542678A5 (https=) | ||
| JP2015537009A5 (https=) | ||
| JP2009541409A5 (https=) | ||
| RU2007107368A (ru) | Композиция, содержащая десмопрессин | |
| JP2014218523A5 (https=) | ||
| NO20090262L (no) | Galeniske formuleringer av aliskiren og hydroklorotiazid | |
| JP2009505991A5 (https=) | ||
| JP2015129124A5 (https=) | ||
| EP2315589A4 (en) | PHARMACEUTICAL PRODUCT COMPRISING A MUSCARINIC RECEPTOR ANTAGONIST AND A beta2-ADRENOCEPTOR AGONIST | |
| JP2016523943A5 (https=) |